Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2560 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA accepts Savient’s BLA for gout drug

The FDA also granted the company’s biologics license application (BLA) with a priority review status which accelerates the review period to six months. A priority review designation is

Adaltis Appoints New Vice-President Finance

She will succeed Jacques Deforges, the company’s current vice-president and chief financial officer, who will leave the company to pursue other interests. Cheung graduated from the University of

King Pharmaceuticals acquires Alpharma

As of the expiration of the tender offer, approximately 35.25m shares of class A common stock of Alpharma, were validly tendered and not withdrawn pursuant to the tender